NCT05235984 (Screenbeat) is a clinical trial in Sleep Apnea, sponsored by Firstbeat Technologies Oy.

Who is sponsoring NCT05235984?

NCT05235984 is sponsored by Firstbeat Technologies Oy.

What condition does NCT05235984 study?

NCT05235984 studies Sleep Apnea, Sleep Disorder.

Is NCT05235984 still recruiting?

NCT05235984 is currently completed. Last updated 11 October 2023.

Last reviewed 2023-10-11 · How we verify

NCT05235984: Screenbeat

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Technical Feasibility Study on Screening Sleep Related Breathing Disturbances and Sleep Apnoea With Wearable Sensors

Completed Last updated 11 October 2023

What this trial tests

trial in Sleep Apnea in 30 participants. Completed in 30 September 2023.

Timeline

18 July 2022

Primary endpoint
30 September 2023

30 September 2023

Quick facts

Lead sponsor	Firstbeat Technologies Oy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	18 July 2022
Primary completion	30 September 2023
Estimated completion	30 September 2023
Sites	1 location across Finland

Conditions studied

Sleep Apnea — all drugs for Sleep Apnea →
Sleep Disorder — all drugs for Sleep Disorder →

Sponsor

Firstbeat Technologies Oy

Who can join

Adults 18 to 65, any sex, with Sleep Apnea or Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study the feasibility of detecting sleep apnoeas with unobtrusive wearable sensors and sounds recorded with a smartphone is studied by making an overnight recording to patients with high probability of sleep apnoeas. The data acquired with the aforementioned devices is: ECG, acceleration, bioimpedance of thorax and processed and raw audio. In data analysis phase it will be studied which combinations of these signals would enable detecting sleep apnoeas with high enough sensitivity and specificity when compared to a night polygraphy reference (Nox T3 device using airflow, breathing movements, audio, position, movement, oxygen saturation, pulse and leg EMG).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Apnea

Currently open trials in the same condition.

NCT07086742 — Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate · NA · recruiting
NCT07243405 — Neurostimulation for Sleep Disordered Breathing (SDB) · NA · recruiting
NCT06931028 — A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2 · Phase 3 · recruiting
NCT06649929 — Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Coup · Phase 2 · recruiting
NCT06755840 — Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05235984 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Firstbeat Technologies Oy
Last refreshed: 11 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05235984.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing